Implementation and evaluation of a once-daily amikacin dosing protocol in a long-term care facility

International Journal of Antimicrobial Agents

Volumn 29, Issue 1, 2007, Pages 113-116

  Yoshida, Makiko ^a,b,c   Morita, Ryoko ^c   Lefor, Alan T ^d,e   Nabeshima, Toshitaka ^b,f  

^a SAKAI MUNICIPAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Aoyama Second Hospital   (Japan)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e Jichii Medical University   (Japan)

^f Japanese Drug Organization of Appropriate Use and Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMIKAMYCIN;

AGED; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INFUSION; FEMALE; HUMAN; JAPAN; LETTER; LONG TERM CARE; MALE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT INFECTION; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMIKACIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BODY TEMPERATURE; C-REACTIVE PROTEIN; CREATININE; CROSS INFECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEALTH FACILITIES; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; LEUKOCYTE COUNT; LONG-TERM CARE; MALE; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME;

EID: 33845665307     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.08.033     Document Type: Letter

References (7)

1. Shlaes D.M., Gerding D.N., John Jr. J.F., et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 25 (1997) 584-599
2. Hamilton D., Drew R., Hayward S., Kure J., and Janning S. Improving clinician adherence to vancomycin-use guidelines: results of a pharmacist-based strategy at an academic medical center. Clin Infect Dis 25 (1997) 425 [Abstract 381]
3. John Jr. J.F. What price success? The continuing saga of the toxic:therapeutic ratio in the use of aminoglycoside antibiotics. J Infect Dis 158 (1988) 1-6
4. Bailey T.C., Little J.R., Littenberg B., Reichley R.M., and Dunagan W.C. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 24 (1997) 786-795
5. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
6. Pickering L.K., and Gearhart P. Effect of time and concentration upon interaction between gentamicin, tobramycin, netilmicin, or amikacin and carbenicillin or ticarcillin. Antimicrob Agents Chemother 15 (1979) 592-596
7. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 1993;119:584-93.